PuraPharm’s Strategic Share Restructuring Proposal

PuraPharm Corp. Ltd. (HK:1498) has released an update.

PuraPharm Corp. Ltd. has announced a proposed capital reduction and subdivision of its shares, aiming to lower the par value of each issued share from US$0.1 to US$0.001. This move is expected to reduce the company’s accumulated losses and potentially create a more attractive stock structure for investors. However, these changes are contingent on certain conditions being met, urging shareholders to proceed with caution.

For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.